The effect of combined treatment of Mirena(R) and Provera(R) (MPA) for chronic pelvic pain due to endometriosis.
- Author:
Cheol Hong KIM
1
;
Moon Kyoung CHO
;
So Myung LEE
;
Sung Tack OH
Author Information
1. Department of Obstetrics and Gynecology, Chonnam National University Medical School, Gwangju, Korea. ohst@chonnam.ac.kr
- Publication Type:Original Article
- Keywords:
Chronic pelvic pain;
Endometriosis;
Progestogen
- MeSH:
Breast;
Endometriosis;
Female;
Hemorrhage;
Humans;
Laparoscopy;
Pelvic Pain;
Weight Gain
- From:Korean Journal of Obstetrics and Gynecology
2008;51(1):68-72
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVE: The degree of pain relief and complications after treatment for chronic pelvic pain due to endometirosis were evaluated. METHODS: This study was performed in sixty three patients of endometriosis who have diagnosed by laparoscopy. They were divided in three groups by treatment regimen, Mirena(R) only group (Group A), Mirena(R) plus low-dose MPA group (Group B) and high-dose MPA only group (Group C). After six months, we evaluated the result of treatment by the degree of pain relief and complications of each treatment regimen. RESULTS: The degree of pain relief in Group B was significantly higher than in Group A (p<0.05), and significant difference was not found between Group B and Group C. The frequency of irregular bleeding in Group B was significantly lower than Group A (p<0.05), but not than Group C. The frequency of weight gain in Group B was significantly lower than Group C (p<0.01), but not than Group A. However the frequency of breast tenderness in Group B was significantly higher than Group A (p<0.01), but not than Group C. CONCLUSION: Mirena(R) plus low-dose MPA combined treatment is as effective as high-dose MPA treatment in pain relief with lower side-effects.
